Abstract

A goal of cancer research is to reveal cell subsets linked to continuous clinical outcomes to generate new therapeutic and biomarker hypotheses. We introduce a machine learning algorithm, Risk Assessment Population IDentification (RAPID), that is unsupervised and automated, identifies phenotypically distinct cell populations, and determines whether these populations stratify patient survival. With a pilot mass cytometry dataset of 2 million cells from 28 glioblastomas, RAPID identified tumor cells whose abundance independently and continuously stratified patient survival. Statistical validation within the workflow included repeated runs of stochastic steps and cell subsampling. Biological validation used an orthogonal platform, immunohistochemistry, and a larger cohort of 73 glioblastoma patients to confirm the findings from the pilot cohort. RAPID was also validated to find known risk-stratifying cells and features using published data from blood cancer. Thus, RAPID provides an automated, unsupervised approach for finding statistically and biologically significant cells using cytometry data from patient samples.

Data availability

Annotated flow data files are available at the following link: https://flowrepository.org/id/FR-FCM-Z24K. Patient specific views of population abundance and channel mass signals for all analyzed patients in this study are currently available in Supplementary File 6. RAPID code is currently available on Github, together with example analysis data: https://github.com/cytolab/RAPID

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Nalin Leelatian

    Department of Cell and Developmental Biology, Vanderbilt University, Nashville, United States
    Competing interests
    No competing interests declared.
  2. Justine Sinnaeve

    Department of Cell and Developmental Biology, Vanderbilt University, Nashville, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9303-7969
  3. Akshitkumar M Mistry

    Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7918-5153
  4. Sierra M Barone

    Department of Cell and Developmental Biology, Vanderbilt University, Nashville, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5944-750X
  5. Asa A Brockman

    Department of Cell and Developmental Biology, Vanderbilt University, Nashville, United States
    Competing interests
    No competing interests declared.
  6. Kirsten E Diggins

    Department of Cell and Developmental Biology, Vanderbilt University, Nashville, United States
    Competing interests
    No competing interests declared.
  7. Allison R Greenplate

    Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
  8. Kyle D Weaver

    Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
  9. Reid C Thompson

    Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
  10. Lola B Chambless

    Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
  11. Bret C Mobley

    Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    No competing interests declared.
  12. Rebecca A Ihrie

    Department of Cell and Developmental Biology, Vanderbilt University, Nashville, United States
    For correspondence
    rebecca.ihrie@vanderbilt.edu
    Competing interests
    No competing interests declared.
  13. Jonathan M Irish

    Department of Cell and Developmental Biology, Vanderbilt University, Nashville, United States
    For correspondence
    jonathan.irish@vanderbilt.edu
    Competing interests
    Jonathan M Irish, was a co-founder and a board member of Cytobank Inc. and received research support from Incyte Corp, Janssen, and Pharmacyclics.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9428-8866

Funding

National Institutes of Health (R00 CA143231)

  • Jonathan M Irish

National Institutes of Health (F31 CA199993)

  • Allison R Greenplate

National Institutes of Health (R25 CA136440-04)

  • Kirsten E Diggins

Vanderbilt Ingram Cancer Center (Provocative Question)

  • Jonathan M Irish

National Institutes of Health (R01 CA226833)

  • Jonathan M Irish

National Institutes of Health (U54 CA217450)

  • Jonathan M Irish

National Institutes of Health (U01 AI125056)

  • Sierra M Barone
  • Jonathan M Irish

National Institutes of Health (R01 NS096238)

  • Rebecca A Ihrie

U.S. Department of Defense (W81XWH-16-1-0171)

  • Rebecca A Ihrie

Michael David Greene Brain Cancer Fund

  • Rebecca A Ihrie
  • Jonathan M Irish

Vanderbilt Institute for Clinical and Translational Research (VR51342)

  • Bret C Mobley
  • Rebecca A Ihrie

Vanderbilt Ingram Cancer Center (P30 CA68485)

  • Jonathan M Irish

Vanderbilt Ingram Cancer Center (Ambassadors Award)

  • Rebecca A Ihrie
  • Jonathan M Irish

Southeastern Brain Tumor Foundation

  • Rebecca A Ihrie
  • Jonathan M Irish

Vanderbilt University (International Scholars Program)

  • Nalin Leelatian

Vanderbilt University (Discovery Grant)

  • Nalin Leelatian
  • Jonathan M Irish

Alpha Omega Alpha Honor Medical Society (Postgraduate Award)

  • Akshitkumar M Mistry

Society of Neurological Surgeons (RUNN Award)

  • Akshitkumar M Mistry

National Institutes of Health (F32 CA224962-01)

  • Akshitkumar M Mistry

Burroughs Wellcome Fund (1018894)

  • Akshitkumar M Mistry

National Institutes of Health (T32 HD007502)

  • Justine Sinnaeve

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. C Daniela Robles-Espinoza, International Laboratory for Human Genome Research, Mexico

Version history

  1. Received: March 12, 2020
  2. Accepted: June 4, 2020
  3. Accepted Manuscript published: June 23, 2020 (version 1)
  4. Version of Record published: July 7, 2020 (version 2)

Copyright

© 2020, Leelatian et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,633
    views
  • 447
    downloads
  • 21
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nalin Leelatian
  2. Justine Sinnaeve
  3. Akshitkumar M Mistry
  4. Sierra M Barone
  5. Asa A Brockman
  6. Kirsten E Diggins
  7. Allison R Greenplate
  8. Kyle D Weaver
  9. Reid C Thompson
  10. Lola B Chambless
  11. Bret C Mobley
  12. Rebecca A Ihrie
  13. Jonathan M Irish
(2020)
Unsupervised machine learning reveals risk stratifying glioblastoma tumor cells
eLife 9:e56879.
https://doi.org/10.7554/eLife.56879

Share this article

https://doi.org/10.7554/eLife.56879

Further reading

    1. Computational and Systems Biology
    2. Neuroscience
    Sara Ibañez, Nilapratim Sengupta ... Christina M Weaver
    Research Article

    Normal aging leads to myelin alterations in the rhesus monkey dorsolateral prefrontal cortex (dlPFC), which are positively correlated with degree of cognitive impairment. It is hypothesized that remyelination with shorter and thinner myelin sheaths partially compensates for myelin degradation, but computational modeling has not yet explored these two phenomena together systematically. Here, we used a two-pronged modeling approach to determine how age-related myelin changes affect a core cognitive function: spatial working memory. First, we built a multicompartment pyramidal neuron model fit to monkey dlPFC empirical data, with an axon including myelinated segments having paranodes, juxtaparanodes, internodes, and tight junctions. This model was used to quantify conduction velocity (CV) changes and action potential (AP) failures after demyelination and subsequent remyelination. Next, we incorporated the single neuron results into a spiking neural network model of working memory. While complete remyelination nearly recovered axonal transmission and network function to unperturbed levels, our models predict that biologically plausible levels of myelin dystrophy, if uncompensated by other factors, can account for substantial working memory impairment with aging. The present computational study unites empirical data from ultrastructure up to behavior during normal aging, and has broader implications for many demyelinating conditions, such as multiple sclerosis or schizophrenia.

    1. Computational and Systems Biology
    2. Neuroscience
    Andrea I Luppi, Pedro AM Mediano ... Emmanuel A Stamatakis
    Research Article

    How is the information-processing architecture of the human brain organised, and how does its organisation support consciousness? Here, we combine network science and a rigorous information-theoretic notion of synergy to delineate a ‘synergistic global workspace’, comprising gateway regions that gather synergistic information from specialised modules across the human brain. This information is then integrated within the workspace and widely distributed via broadcaster regions. Through functional MRI analysis, we show that gateway regions of the synergistic workspace correspond to the human brain’s default mode network, whereas broadcasters coincide with the executive control network. We find that loss of consciousness due to general anaesthesia or disorders of consciousness corresponds to diminished ability of the synergistic workspace to integrate information, which is restored upon recovery. Thus, loss of consciousness coincides with a breakdown of information integration within the synergistic workspace of the human brain. This work contributes to conceptual and empirical reconciliation between two prominent scientific theories of consciousness, the Global Neuronal Workspace and Integrated Information Theory, while also advancing our understanding of how the human brain supports consciousness through the synergistic integration of information.